[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
Goriacheva
L G
LG
Romantsov
M G
MG
Agaeva
S G
SG
Lin'kov
Iu N
IuN
Kovalenko
A L
AL
D000166:Acridines / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007369:Interferon Inducers / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D012008:Recurrence
D000166:Acridines; D000998:Antiviral Agents; D007155:Immunologic Factors; D007369:Interferon Inducers; D016898:Interferon-alpha; C026430:10-carboxymethyl-9-acridanone